Hepatitis C Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: H461A5D59526EN
Market Monitor Global

Abstracts

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.

This report contains market size and forecasts of Hepatitis C Drugs in Global, including the following market information:

Global Hepatitis C Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatitis C Drugs market was valued at 6415.7 million in 2021 and is projected to reach US$ 7975.7 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-Viral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis C Drugs include Gilead sciences, Abbvi, Johnson & Johnson, Merck, Glaxosmithkline, Novartis, Bristol-Myers Squibb and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis C Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis C Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis C Drugs Market Segment Percentages, by Type, 2021 (%)

• Anti-Viral
• Immuno-modulators
• Others

Global Hepatitis C Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis C Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Hepatitis C Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatitis C Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis C Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatitis C Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead sciences
• Abbvi
• Johnson & Johnson
• Merck
• Glaxosmithkline
• Novartis
• Bristol-Myers Squibb
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis C Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis C Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS C DRUGS OVERALL MARKET SIZE

2.1 Global Hepatitis C Drugs Market Size: 2021 VS 2028
2.2 Global Hepatitis C Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatitis C Drugs Players in Global Market
3.2 Top Global Hepatitis C Drugs Companies Ranked by Revenue
3.3 Global Hepatitis C Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis C Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis C Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis C Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Hepatitis C Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatitis C Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatitis C Drugs Market Size Markets, 2021 & 2028
  4.1.2 Anti-Viral
  4.1.3 Immuno-modulators
  4.1.4 Others
4.2 By Type - Global Hepatitis C Drugs Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis C Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Hepatitis C Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Hepatitis C Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis C Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Hepatitis C Drugs Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis C Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Hepatitis C Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Hepatitis C Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis C Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis C Drugs Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis C Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Hepatitis C Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatitis C Drugs Revenue, 2017-2028
  6.3.2 US Hepatitis C Drugs Market Size, 2017-2028
  6.3.3 Canada Hepatitis C Drugs Market Size, 2017-2028
  6.3.4 Mexico Hepatitis C Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatitis C Drugs Revenue, 2017-2028
  6.4.2 Germany Hepatitis C Drugs Market Size, 2017-2028
  6.4.3 France Hepatitis C Drugs Market Size, 2017-2028
  6.4.4 U.K. Hepatitis C Drugs Market Size, 2017-2028
  6.4.5 Italy Hepatitis C Drugs Market Size, 2017-2028
  6.4.6 Russia Hepatitis C Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatitis C Drugs Market Size, 2017-2028
  6.4.8 Benelux Hepatitis C Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatitis C Drugs Revenue, 2017-2028
  6.5.2 China Hepatitis C Drugs Market Size, 2017-2028
  6.5.3 Japan Hepatitis C Drugs Market Size, 2017-2028
  6.5.4 South Korea Hepatitis C Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatitis C Drugs Market Size, 2017-2028
  6.5.6 India Hepatitis C Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatitis C Drugs Revenue, 2017-2028
  6.6.2 Brazil Hepatitis C Drugs Market Size, 2017-2028
  6.6.3 Argentina Hepatitis C Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatitis C Drugs Revenue, 2017-2028
  6.7.2 Turkey Hepatitis C Drugs Market Size, 2017-2028
  6.7.3 Israel Hepatitis C Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatitis C Drugs Market Size, 2017-2028
  6.7.5 UAE Hepatitis C Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead sciences
  7.1.1 Gilead sciences Corporate Summary
  7.1.2 Gilead sciences Business Overview
  7.1.3 Gilead sciences Hepatitis C Drugs Major Product Offerings
  7.1.4 Gilead sciences Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.1.5 Gilead sciences Key News
7.2 Abbvi
  7.2.1 Abbvi Corporate Summary
  7.2.2 Abbvi Business Overview
  7.2.3 Abbvi Hepatitis C Drugs Major Product Offerings
  7.2.4 Abbvi Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.2.5 Abbvi Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Hepatitis C Drugs Major Product Offerings
  7.3.4 Johnson & Johnson Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Hepatitis C Drugs Major Product Offerings
  7.4.4 Merck Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Glaxosmithkline
  7.5.1 Glaxosmithkline Corporate Summary
  7.5.2 Glaxosmithkline Business Overview
  7.5.3 Glaxosmithkline Hepatitis C Drugs Major Product Offerings
  7.5.4 Glaxosmithkline Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.5.5 Glaxosmithkline Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Hepatitis C Drugs Major Product Offerings
  7.6.4 Novartis Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Bristol-Myers Squibb
  7.7.1 Bristol-Myers Squibb Corporate Summary
  7.7.2 Bristol-Myers Squibb Business Overview
  7.7.3 Bristol-Myers Squibb Hepatitis C Drugs Major Product Offerings
  7.7.4 Bristol-Myers Squibb Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Key News
7.8 Roche
  7.8.1 Roche Corporate Summary
  7.8.2 Roche Business Overview
  7.8.3 Roche Hepatitis C Drugs Major Product Offerings
  7.8.4 Roche Hepatitis C Drugs Revenue in Global Market (2017-2022)
  7.8.5 Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatitis C Drugs Market Opportunities & Trends in Global Market
Table 2. Hepatitis C Drugs Market Drivers in Global Market
Table 3. Hepatitis C Drugs Market Restraints in Global Market
Table 4. Key Players of Hepatitis C Drugs in Global Market
Table 5. Top Hepatitis C Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis C Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis C Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis C Drugs Product Type
Table 9. List of Global Tier 1 Hepatitis C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis C Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis C Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis C Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis C Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatitis C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis C Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis C Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis C Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis C Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Gilead sciences Corporate Summary
Table 31. Gilead sciences Hepatitis C Drugs Product Offerings
Table 32. Gilead sciences Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Abbvi Corporate Summary
Table 34. Abbvi Hepatitis C Drugs Product Offerings
Table 35. Abbvi Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Hepatitis C Drugs Product Offerings
Table 38. Johnson & Johnson Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Hepatitis C Drugs Product Offerings
Table 41. Merck Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline Hepatitis C Drugs Product Offerings
Table 44. Glaxosmithkline Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Hepatitis C Drugs Product Offerings
Table 47. Novartis Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Hepatitis C Drugs Product Offerings
Table 50. Bristol-Myers Squibb Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Hepatitis C Drugs Product Offerings
Table 53. Roche Hepatitis C Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatitis C Drugs Segment by Type in 2021
Figure 2. Hepatitis C Drugs Segment by Application in 2021
Figure 3. Global Hepatitis C Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis C Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis C Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis C Drugs Revenue in 2021
Figure 8. By Type - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 12. US Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 24. China Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis C Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis C Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead sciences Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbvi Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxosmithkline Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Hepatitis C Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)